Press Release November 16, 2021The European Commission Grants Marketing Authorization for VUMERITY® (diroximel fumarate) as Oral Treatment for Relapsing-Remitting Multiple Sclerosis 0 0 Share
Press Release November 15, 2021Biogen Sets Industry Record with Recognition on Dow Jones Sustainability World Index for 9th Consecutive Year 0 0 Share
Company Ticker News November 10, 2021Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters 0 0 Share
Press Release November 3, 2021Biogen Announces Late Breakers and Additional New Data Presentations at the 2021 Clinical Trials on Alzheimer's Disease (CTAD) Meeting 0 0 Share
Company Ticker News October 29, 2021Biogen Beat Earnings and Raised Guidance. Here's Why I Still Wouldn't Buy the Stock 0 0 Share
